Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 3 Seizures 1 Neoplasms 1 Epilepsy 1

Interventions

Levetiracetam 6 Cannabidiol 4 perampanel 2 Standard of Care 2 Everolimus 2 enzalutamide 1 Vigabatrin 1 Tranexamic Acid 1 Temozolomide 1 Sodium Chloride 1 Saline Solution 1 Pregabalin 1 Medical Marijuana 1 Magnesium Sulfate 1 Drug Therapy 1 Curcumin 1 Cholecalciferol 1 Aspirin 1 Anticonvulsants 1 Anastrozole 1 Airway Extubation 1 2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Seizures × Vigabatrin × Clear all

NCT01266291 2017-07-12

STARS

University of Pennsylvania

Phase 4 Terminated

1 enrolled 8 charts

Seizures, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡